NCT00413621 MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems Status COMPLETED Phase N/A
NCT00412048 Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease Status WITHDRAWN Phase NA
NCT00411580 Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) Status COMPLETED Phase PHASE1
NCT00408525 Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00403520 Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers Status COMPLETED Phase PHASE4
NCT00401167 Memantine for Agitation and Aggression in Severe Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT00392912 Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone Status COMPLETED Phase NA
NCT00391833 Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00384423 Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept Status COMPLETED Phase PHASE2
NCT00381381 The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT00381238 Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00380276 Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol Status TERMINATED Phase PHASE3
NCT00377715 Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients Status WITHDRAWN Phase PHASE4
NCT00369603 Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients Status TERMINATED Phase PHASE4
NCT00362024 MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) Status TERMINATED Phase PHASE2
NCT00359944 Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2